Journal of Antivirals & Antiretrovirals
Open Access

Department of Infectious Disease and Clinical Microbiology, Erzincan Binali Yildirim University, Erzincan, Turkey

Biography

He works at Erzincan University in the department of infectious diseases and clinical microbiology. His area of research interests are Clinical Microbiology, Medical Microbiology, Antibiotic Resistance, Bacteriology, Bacterial Antibiotic Resistance. He published several articles in relevant journals.

Publications

• Research Article   
  Level of SARS-CoV-2 IgG Antibodies after a Single Dose CoronaVac Vaccine: Primarily Report
  Author(s): Umut Devrim Binay*, Faruk Karakecili, Orcun Barkay, Ozlem Gul and Cuma Mertoglu
  
  Background: It is necessary to use an effective vaccine to end the COVID-19 pandemic. CoronaVac vaccine is used in our country and we aimed to examine the level of antibody development after the first dose. Methods: This is a retrospective, cross-sectional research. The data of the people, who applied to a university hospital between January and February 2021,were analyzed. Those who had SARS-CoV-2 IgG and IgM measurement in the previous two weeks before the CoronoVac vaccine, and those who were both found negative and who had SARS-CoV-2 IgG and IgM measurement after the first dose of CoronaVac vaccine were included in the research. SARS-CoV-2 IgG/IgM were measured by VIDAS® (BioMérieux, Marcy-l'Etoile, France) device for the detection of spike protein specific IgG/IgM of SARS-CoV-2 in human serum with E.. View More»
  DOI: 10.35248/1948-5964.21.s18.004

  Abstract HTML PDF